X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (147) 147
female (138) 138
oncology (123) 123
index medicus (121) 121
breast cancer (104) 104
mutation (97) 97
adult (89) 89
breast neoplasms - genetics (88) 88
middle aged (85) 85
risk factors (81) 81
aged (63) 63
cancer (61) 61
genes, brca1 (57) 57
brca1 (54) 54
genetic aspects (54) 54
genetic predisposition to disease (50) 50
heterozygote (50) 50
ovarian cancer (50) 50
women (49) 49
genes, brca2 (47) 47
medicin och hälsovetenskap (43) 43
skin and connective tissue diseases (43) 43
medical and health sciences (42) 42
ovarian neoplasms - genetics (42) 42
brca1 protein - genetics (41) 41
gene mutations (41) 41
health aspects (40) 40
research (40) 40
brca2 (37) 37
article (36) 36
risk (36) 36
ovarian-cancer (33) 33
brca2 protein - genetics (32) 32
breast neoplasms - pathology (31) 31
case-control studies (30) 30
klinisk medicin (30) 30
cancer och onkologi (29) 29
clinical medicine (29) 29
cancer and oncology (28) 28
risk assessment (27) 27
endocrine system diseases (26) 26
breast-cancer (24) 24
aged, 80 and over (22) 22
brca1 protein (21) 21
young adult (21) 21
breast neoplasms - epidemiology (20) 20
genes (20) 20
prognosis (20) 20
brca2 protein (19) 19
medicine & public health (19) 19
prevention (19) 19
adolescent (18) 18
breast (18) 18
chemotherapy (18) 18
expression (17) 17
neoplasm staging (17) 17
odds ratio (17) 17
polymorphism, single nucleotide (17) 17
age (16) 16
age factors (16) 16
breast neoplasms - prevention & control (16) 16
carriers (16) 16
cohort studies (16) 16
genotype (16) 16
germline mutations (16) 16
oncology, experimental (16) 16
breast neoplasms - drug therapy (15) 15
diagnosis (15) 15
epidemiology (15) 15
germ-line mutation (15) 15
population (15) 15
care and treatment (14) 14
medicine (14) 14
prospective studies (14) 14
surgery (14) 14
survival (14) 14
health risk assessment (13) 13
male (13) 13
mastectomy (13) 13
medical genetics (13) 13
mutation - genetics (13) 13
obstetrics & gynecology (13) 13
ovarian neoplasms - pathology (13) 13
pregnancy (13) 13
therapy (13) 13
brca mutations (12) 12
genetics & heredity (12) 12
penetrance (12) 12
treatment outcome (12) 12
brca2 mutation carriers (11) 11
breast neoplasms - surgery (11) 11
family-history (11) 11
genetic testing (11) 11
genome-wide association (11) 11
hematology, oncology and palliative medicine (11) 11
incidence (11) 11
medicine, general & internal (11) 11
mutation carriers (11) 11
ovariectomy (11) 11
phenotype (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 6, pp. 523 - 533
Journal Article
JAMA: Journal of the American Medical Association, ISSN 0098-7484, 06/2011, Volume 305, Issue 21, pp. 2211 - 2220
Ms E, a 41-year-old BRCA1 mutation carrier, was diagnosed 4 years ago as having breast cancer and opted for breast-conserving therapy. Prior to receiving... 
Journal Article
JAMA, The Journal of the American Medical Association, ISSN 0098-7484, 06/2011, Volume 305, Issue 21, p. 2211
The article discusses the case of a 41-year-o ld woman with a BRCA mutation and a recent history of breast cancer to arrive at a better understanding of... 
Case studies | Care and treatment | BRCA mutations | Breast cancer | Research | Diagnosis | Risk factors
Journal Article
British Journal of Cancer, ISSN 0007-0920, 07/2018, Volume 119, Issue 2, pp. 141 - 152
Testing for germline BRCA1/2 mutations has an established predictive role in breast cancer risk assessment. More recently, studies have also identified BRCA1/2... 
PLATINUM-BASED THERAPY | POLY(ADP-RIBOSE) POLYMERASE | DNA-REPAIR DEFECT | RIBOSE POLYMERASE INHIBITORS | ONCOLOGY | HOMOLOGOUS RECOMBINATION DEFICIENCY | MUTATION CARRIERS | OVARIAN-CANCER | PHASE-I | SOMATIC MUTATIONS | PATHOLOGICAL COMPLETE RESPONSE | Humans | Ovarian Neoplasms - pathology | Piperazines - therapeutic use | Poly(ADP-ribose) Polymerase Inhibitors - adverse effects | DNA Repair - genetics | Germ-Line Mutation - genetics | Breast Neoplasms - drug therapy | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Phthalazines - therapeutic use | Breast Neoplasms - genetics | Poly(ADP-ribose) Polymerases - genetics | Breast Neoplasms - pathology | Progression-Free Survival | Female | Ovarian Neoplasms - drug therapy | BRCA2 Protein - genetics | Phthalazines - adverse effects | Salts | Ovarian carcinoma | Homologous recombination | Poly(ADP-ribose) | Homology | Taxane | ADP | Cancer therapies | DNA repair | Subgroups | Ovarian cancer | Homologous recombination repair | Pathways | Ribose | Platinum | Risk assessment | Repair | Deoxyribonucleic acid--DNA | BRCA1 protein | Health risks | Poly(ADP-ribose) polymerase | Breast cancer | Patients | Polymerase | Chemotherapy | Inhibitors | Anthracycline | Breast | Mutation | Health risk assessment | Cancer | Review
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 02/2018, Volume 16, Issue 2, pp. 97 - 101
Journal Article
BREAST CANCER RESEARCH, ISSN 1465-5411, 09/2019, Volume 21, Issue 1, pp. 1 - 10
The introduction of next-generation sequencing has resulted in testing multiple genes simultaneously to identify inherited pathogenic variants (PVs) in cancer... 
Pathogenic variant | DE-NOVO | SERIES | Clonal hematopoiesis | POLYGENIC SUSCEPTIBILITY | Hereditary breast cancer | PPM1D | BREAST-CANCER | TRANSMISSION | ONCOLOGY | Mosaicism | PATIENT | Mutation | Low allele frequency | MUTATIONS | TP53 | Li-Fraumeni syndrome | BLOOD | Usage | Mastectomy | Breast cancer | Nucleotide sequencing | Diagnosis | Research | DNA sequencing | Review
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2008, Volume 105, Issue 20, pp. 7275 - 7280
Journal Article
JAMA, ISSN 0098-7484, 09/2010, Volume 304, Issue 9, pp. 967 - 975
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2016, Volume 34, Issue 34, pp. 4187 - 4188
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2010, Volume 28, Issue 7, pp. 1145 - 1153
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2007, Volume 8, Issue 1, pp. 26 - 34
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 02/2019, Volume 26, Issue 2, pp. 366 - 371
The Oncotype DX assay has been validated in predicting response to adjuvant chemotherapy in breast cancer. Its role in neoadjuvant chemotherapy (NCT) has not... 
Journal Article
JNCI: Journal of the National Cancer Institute, ISSN 0027-8874, 10/2017, Volume 109, Issue 10
Journal Article